You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. Stocks
  2. BridgeBio Pharma Inc
  3. Swot
swot-logo

BridgeBio Pharma Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

BridgeBio Pharma Inc has 20 Strengths, 3 Weaknesses, 2 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Rising Momentum: Momentum Score Weekly Gainers

High Normalized Momentum Score

Consistent Highest Return Stocks over Five Years - Nifty500

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Week

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over the Quarter (3 Months)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

MACD crossed above zero line previous end of day

Increasing Revenue every quarter for the past 2 quarters

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Top Gainers

Stock with Low PE (PE < = 10)

RSI indicating price strength

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Low Piotroski Score : Companies with weak financials

Declining profits every quarter for the past 3 quarters

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mutual Funds Decreased Shareholding in Past Month

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks